[CPE chemotherapy for tongue carcinoma--clinical effects and side effects].
Recent advances in chemotherapy have markedly improved the treatment results for oral cancer. Among many chemotherapeutic regimens, the usefulness of multiple combination chemotherapy with cisplatin as the primary drug has been frequently reported. During the past 6-year period, we have performed combination chemotherapy with cisplatin as the primary drug, peplomycin, and etoposide (CPE chemotherapy) as one of the chemotherapeutic regimens for oral cancer. The subjects were 11 patients (7 males and 4 females) with tongue cancer treated by CPE chemotherapy as neoadjuvant chemotherapy at our department between March, 1990 and April, 1995.


RESULTS
PR in 8 (73%), and NC in 3 (27%). No patient showed CR and PD. The side effects observed were reversible findings such as transient myelosuppression, nausea-vomiting, and alopecia. No patient showed severe or persistent suppression of hematopoietic function.
Yamamoto
C
C
Dept. of Oral and Maxillofacial Surgery, Shiga University of Medical Science.
Kutsuki
M
M
Nishikawa
M
M
Nishimura
K
K
Inoda
H
H
Takigami
K
K
Mori
M
M
Yamaguchi
Y
Y
Yoshitake
K
K
D000505:Alopecia / Q000139:chemically induced; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D017663:Peplomycin / Q000008:administration & dosage / Q000009:adverse effects; D014062:Tongue Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D017663:Peplomycin; D005047:Etoposide; D002945:Cisplatin